Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is unclear, supply chain experts said.

From the founders of BoldType comes CyberMed, a new company dedicated exclusively to MedTech cybersecurity. With a mission to ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 60,000 newsletter subscribers for 21 days.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...